The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant fusarium keratitis

Cornea

Volumn 30, Issue 8, 2011, Pages 872-875

  Siatiri, Heidar ^a   Daneshgar, Farid ^a   Siatiri, Nasim ^b   Khodabande, Alireza ^b  

^a Cornea Department ^*  (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

corneal abscess; fungal keratitis; Fusarium; voriconazole

Indexed keywords

KETOCONAZOLE; NATAMYCIN; VORICONAZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA STROMA; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FUSARIUM; HUMAN; INTRASTROMAL DRUG ADMINISTRATION; KERATOMYCOSIS; MALE; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; CORNEAL STROMA; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; FUSARIUM; HUMANS; INJECTIONS, INTRAOCULAR; MALE; MYCOSES; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 79960698215     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182100993     Document Type: Article

References (19)

1. Alfonso EC, Rosa RH, Miller D. In: Krachmer JH, Mannis MY, Holland EY, eds. Fungal keratitis. Cornea. 2nd ed. Philadelphia, PA: Elsevier Mosby; 2005:1101-1122.
2. Dursun D, Fernandez V, Miller D, et al. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea. 2003;22:300-303. (Pubitemid 36578525)
3. Sony P, Sharma N, Vajpaee RB, et al. Therapeutic keratoplasty for infectious keratitis: a review of literature. CLAO J. 2002;28:111-118.
4. Sirnivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15:321-327.
5. Sabo JA, Abdel-Rahman SM. Voriconazole: a new triazole antifungal. Ann Pharmacother. 2000;34:1032-1043. (Pubitemid 30660782)
6. Sponel W, Chen N, Dang D, et al. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother. 2006;50: 262-268. (Pubitemid 43042931)
7. Polizzi A, Siniscalchi C, Mastromarino A, et al. Effect of voriconazole on a corneal abscess caused by Fusarium. Acta Ophthalmol Scand. 2004;82:762-764. (Pubitemid 40057791)
8. Verma S, Tuft SJ. Fusarium solani keratitis following LASIK for myopia. Br J Ophthalmol. 2002;86:1190-1191.
9. Klont RR, Eggrink C, Rijs AYMM, et al. Successful treatment of Fusarium keratitis with corneal transplantation and topical and systemic voriconazole. Clin Infect Dis. 2005;40:110-112.
10. Nulens E, Eggink C, Rijs AYMM, et al. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol. 2003;41:2261-2264. (Pubitemid 36576583)
11. Prakash G, Sharma N, Goel M, et al. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol. 2008;146:56-59.
12. Garsia-Valenzuela E, Song CD. Intrastromal injection of amphotericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol. 2005;123:1721-1723. (Pubitemid 41785107)
13. Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea. 2007;26:814-818.
14. Tu EY. Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. Cornea. 2009;28:116-119.
15. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother. 2008;61:805-809. (Pubitemid 351426063)
16. Nucci M, Annaissie E. Fusarium infection in immunocompromised patients. Clin Microbial Rev. 2007;20:659-704.
17. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997;41:275-312.
18. Lv YP, Wang XY, Song BA, et al. Synthesis, antiviral and antifungal bioactivity of 2-cyano-acrylate derivatives containing phosphonyl moieties. Molecules. 2007;12:965-978.
19. Chang CW, Ho CK, Chen ZC, et al. Fungi genus and concentration in the air of onion fields and their opportunistic action related to mycotic keratitis. Arch Environ Health. 2002;57:349-354.